Search

A former teacher and volunteer firefighter benefits from less-intense treatment for early stage-esophageal cancer.

… Thursday, March 10, 2022 Joe Ryan has always enjoyed the luck of the Irish. A former middle-school teacher and current volunteer firefighter in upstate New York, the 71-year-old was still fit, working part-time, and in good health. But a sudden onset of stomach problems in 2018 caused his wife to worry

Each year since 2007, Memorial Sloan Kettering's postdoctoral researchers have had the opportunity to showcase their research accomplishments at the annual Postdoctoral Research Symposium.

… Monday, February 1, 2010 Summary Each year since 2007, Memorial Sloan Kettering’s postdoctoral researchers have had the opportunity to showcase their research accomplishments at the annual Postdoctoral Research Symposium. Each year since 2007, Memorial Sloan Kettering’s postdoctoral researchers have

Memorial Sloan Kettering has made an important step forward in efficiently diagnosing gene mutations in patients' cancers on an individual basis.

… Tuesday, June 1, 2010 Summary Memorial Sloan Kettering has made an important step forward in efficiently diagnosing gene mutations in patients’ cancers on an individual basis. As the number of targeted cancer therapies grows, it is becoming increasingly important that hospital laboratories be able to

During World War II, US factories famously converted their operations to support the war effort. COVID-19 instigated something similar among cancer scientists.

… Friday, January 8, 2021 Summary When COVID-19 hit, cancer researchers at MSK used their expertise in genomics to help solve the mystery of how the virus infects human cells. “I remember thinking I wanted to do something,” recalls Francisco J. Sánchez-Rivera , a postdoctoral fellow in Scott Lowe’s lab

A number of Gerstner Sloan Kettering students working in labs across MSK have received prestigious fellowships granted by external agencies and benefactors of the school.

… Friday, August 29, 2025 This past year, seven PhD students enrolled in the  Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) were awarded competitive fellowships from prestigious external agencies such as the National Institutes of Health (NIH) and the National Science Foundation

Memorial Sloan Kettering Cancer Center and MediSys Health Network today announced a new collaboration that will expand access to world-class cancer care for the people of Queens and eastern Brooklyn.

… Thursday, January 12, 2023 Memorial Sloan Kettering Cancer Center (MSK) and MediSys Health Network (Jamaica Hospital Medical Center and Flushing Hospital Medical Center) today announced a new collaboration that will expand access to world-class cancer care for the people of Queens and eastern Brooklyn

A vital part of MSK's mission is to get patients back to feeling like themselves.

… Wednesday, July 12, 2017 VIDEO | 01:35 MSK's Dental Service Aims to Make People Whole Again Medical artist Marjorie Golden and Dental Service Chief Joseph Huryn create lifelike facial prostheses for patients. Video Details Summary A vital part of MSK’s mission is to get patients back to feeling like

MSK’s comprehensive program for patients with upper tract urothelial carcinoma (UTUC) offers kidney-sparing treatment options whenever possible.

… Tuesday, April 16, 2024 MSK’s comprehensive program for patients with upper tract urothelial carcinoma (UTUC) offers kidney-sparing treatment options whenever possible. “Traditionally, radical nephroueterectomy has been the gold standard for managing high-risk UTUC,” said  urologic surgeon Jonathan Coleman

Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program, is a co-recipient of the 2011 Stanley J. Korsmeyer Award from the American Society for Clinical Investigation.

… Friday, July 1, 2011 Summary Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program, is a co-recipient of the 2011 Stanley J. Korsmeyer Award from the American Society for Clinical Investigation. Charles L. Sawyers , Chair of the Human Oncology and Pathogenesis Program , is a co-recipient

Laboratory research led by MSK and Cold Spring Harbor Laboratory demonstrates the potential for CAR T cells to improve “healthspan” by eliminating senescent cells associated with aging-related diseases.

… Thursday, February 1, 2024 Highlights Laboratory research led by MSK and Cold Spring Harbor Laboratory demonstrates the potential for CAR T cells to improve “healthspan” by eliminating senescent cells associated with aging-related diseases. Not only was the treatment able to improve the metabolic function